TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Corey Cutler, MD MS

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

DFCI/Brigham & Women's Hospital


Boston, Massachusetts - 02114 (617-632-2525)
  • CLINICAL TRIALS 3
  • CONDITIONS9
  • INTERVENTIONS3
  • SINCE2006
Improving Outcomes Assessment in Chronic GVHD

September 2007 - June 2012
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)

November 2006 - August 2012
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

October 2010 - September 2012
Leukemia

Leukemia, Lymphoid

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Myelodysplastic Syndromes

Preleukemia

Graft vs Host Disease

Alefacept

Tacrolimus/Methotrexate

Tacrolimus/Sirolimus

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo